• IPR-803 and the Next Frontier in Tumor Microenvironment Modu

  2026-07-03

  This thought-leadership article unpacks the mechanistic and translational significance of IPR-803, a competitive urokinase receptor inhibitor, within the evolving landscape of tumor microenvironment targeting. By weaving together recent mechanistic insights, validated protocols, and strategic outlooks, the article offers translational researchers a blueprint for leveraging IPR-803 in preclinical and emerging nanomedicine workflows—especially for breast and pancreatic cancer. Beyond summarizing current evidence, the discussion highlights how IPR-803 enables a paradigm shift from mere cytotoxicity to stroma and angiogenesis modulation, referencing recent advances in sequential nanomedicine delivery and offering practical guidance for experimental design.

• Translatome Remodeling Links Fasting, Ketogenesis, and Tumor

  2026-07-03

  Yang et al. (2024) reveal that fasting induces selective remodeling of hepatic mRNA translation through the AMPK-MNK-eIF4E axis, controlling ketogenesis and exposing metabolic vulnerabilities in pancreatic tumors. This study uncovers a direct molecular bridge between diet, translational control, and cancer therapy, with implications for targeting the MNK-eIF4E signaling pathway.

• Structural Insights into ASCH Domains and N4-Acetylcytidine

  2026-07-02

  Meng et al. provide the first detailed structural and mechanistic analysis of ASCH domain-containing proteins, revealing that EcYqfB specifically hydrolyzes free N4-acetylcytidine (ac4C) nucleoside but does not remove ac4C from RNA. This work clarifies substrate specificity among ASCH homologs and advances understanding of nucleotide processing in RNA epigenetics research.

• Triamcinolone Protocol Guidance for Glucocorticoid Research

  2026-07-02

  Triamcinolone (SKU B1859) is a synthetic glucocorticoid agonist designed for in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This compound is not suitable for diagnostic or clinical use and demands strict attention to solubility, handling, and storage to ensure data integrity.

• BMS-777607: c-Met Inhibitor Enhances Stem Cell Platelet Prot

  2026-07-01

  BMS-777607, a highly selective c-Met inhibitor, empowers researchers to precisely modulate MET signaling in both cancer and stem cell-derived platelet models. Its integration into hiPSC-to-megakaryocyte workflows accelerates maturation, boosts yield, and offers new cost-effective strategies for scalable platelet production.

• Practical Guide: DiI (DiIC18(3)) Plasma Membrane Orange Fluo

  2026-07-01

  DiI (DiIC18(3)) enables precise, high-contrast plasma membrane labeling in both live and fixed biological systems. It is ideal for neuronal tracing and cell migration workflows but should be avoided in aqueous protocols or for non-membrane organelle labeling. Proper preparation, solubility management, and workflow-specific controls are critical for reproducibility.

• Lactobacillus gasseri Modulates Colitis via E-cadherin Regul

  2026-06-30

  This study demonstrates that Lactobacillus gasseri ATCC33323 ameliorates DSS-induced colitis by regulating E-cadherin expression through the NR1I3 pathway, highlighting a novel mechanism for probiotic intervention in intestinal barrier function. The findings offer mechanistic insights for gut barrier research and suggest new directions for therapeutic strategies targeting inflammatory bowel disease (IBD).

• Nigericin Sodium Salt: Practical Protocols for Ion Transport

  2026-06-30

  Nigericin sodium salt is a potassium ionophore designed for targeted manipulation of ion gradients and cytoplasmic pH in cell-based assays. Its strengths include selectivity for K+/H+ exchange and application in platelet aggregation and lead ion transport studies. Researchers should avoid using it in long-term or aqueous workflows due to stability and solubility constraints.

• BMS-777607: Advanced c-Met Inhibitor for Platelet and Cancer

  2026-06-29

  BMS-777607 delivers precise MET signaling pathway inhibition for both hiPSC-derived platelet differentiation and cancer metastasis research. Its selectivity and versatility empower researchers to optimize protocols, boost efficiency, and overcome long-standing experimental bottlenecks.

• HyperScript First-Strand cDNA Synthesis Kit: Precision in Co

  2026-06-29

  The HyperScript First-Strand cDNA Synthesis Kit delivers unmatched efficiency in first-strand cDNA synthesis from total or poly(A)+ RNA, excelling with complex secondary structures and low-copy transcripts. Applied workflows, recent reference breakthroughs, and actionable troubleshooting position this APExBIO product as a front-runner for robust PCR and qPCR studies.

• Cryo-EM Reveals Structural Diversity in Full-Length Human αv

  2026-06-28

  This study presents high-resolution cryo-EM structures capturing multiple conformations of full-length human integrin αvβ3, including five previously uncharacterized intermediate states. These findings advance our understanding of integrin activation mechanisms, informing the rational design of more precise and effective integrin-targeted therapeutics.

• AMPK–SQSTM1 Feedback Loop Enables Dual Antioxidant Activatio

  2026-06-27

  The referenced study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 during metabolic stress, resulting in simultaneous activation of AMPK and NFE2L2/NRF2 antioxidant pathways. These insights clarify mechanisms of metabolic adaptation in cancer cells and highlight regulatory nodes that may serve as future therapeutic targets.

• CIH-Induced Apoptosis: Microbiome-Metabolite Links and Mdivi

  2026-06-26

  This study reveals that chronic intermittent hypoxia (CIH), a hallmark of obstructive sleep apnea, drives lung apoptosis through disruptions in gut microbiota and metabolite networks. Importantly, the selective DRP1 inhibitor Mdivi-1 was shown to reverse CIH-induced alterations in mitochondrial dynamics and apoptosis, highlighting a novel regulatory axis and therapeutic target.

• Sulfo-NHS-SS-Biotin: Precision Cell Surface Protein Labeling

  2026-06-26

  The Sulfo-NHS-SS-Biotin Kit empowers advanced, reversible cell surface protein and glycoRNA nanodomain analysis, enabling efficient purification and interactome mapping. Its water-soluble, amine-reactive chemistry and cleavable disulfide linker provide unmatched flexibility for both high-throughput proteomics and targeted labeling workflows.

• GRA12: A Conserved Virulence Factor in Toxoplasma gondii Inf

  2026-06-25

  This study uses in vivo CRISPR screens to identify GRA12 as a key, secreted virulence factor essential for acute infection across diverse Toxoplasma gondii strains and mouse subspecies. The findings broaden our understanding of conserved parasite strategies for immune evasion and open new avenues for targeting host-pathogen interactions.

9222 records 1/615 page Next 12345 下5页 Last page